These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 10373425
1. Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. Lin CY, Anders J, Johnson M, Dickson RB. J Biol Chem; 1999 Jun 25; 274(26):18237-42. PubMed ID: 10373425 [Abstract] [Full Text] [Related]
2. Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. Benaud C, Dickson RB, Lin CY. Eur J Biochem; 2001 Mar 25; 268(5):1439-47. PubMed ID: 11231297 [Abstract] [Full Text] [Related]
4. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Oberst M, Anders J, Xie B, Singh B, Ossandon M, Johnson M, Dickson RB, Lin CY. Am J Pathol; 2001 Apr 25; 158(4):1301-11. PubMed ID: 11290548 [Abstract] [Full Text] [Related]
6. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase. Kojima K, Tsuzuki S, Fushiki T, Inouye K. J Biol Chem; 2008 Feb 01; 283(5):2478-87. PubMed ID: 18048349 [Abstract] [Full Text] [Related]
7. Deregulated activation of matriptase in breast cancer cells. Benaud CM, Oberst M, Dickson RB, Lin CY. Clin Exp Metastasis; 2002 Feb 01; 19(7):639-49. PubMed ID: 12498394 [Abstract] [Full Text] [Related]
14. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. Velasco G, Cal S, Quesada V, Sánchez LM, López-Otín C. J Biol Chem; 2002 Oct 04; 277(40):37637-46. PubMed ID: 12149247 [Abstract] [Full Text] [Related]
15. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B. Shia S, Stamos J, Kirchhofer D, Fan B, Wu J, Corpuz RT, Santell L, Lazarus RA, Eigenbrot C. J Mol Biol; 2005 Mar 11; 346(5):1335-49. PubMed ID: 15713485 [Abstract] [Full Text] [Related]
16. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein. Mitchell AC, Kannan D, Hunter SA, Parra Sperberg RA, Chang CH, Cochran JR. J Biol Chem; 2018 Apr 06; 293(14):4969-4980. PubMed ID: 29386351 [Abstract] [Full Text] [Related]
17. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. Denda K, Shimomura T, Kawaguchi T, Miyazawa K, Kitamura N. J Biol Chem; 2002 Apr 19; 277(16):14053-9. PubMed ID: 11805118 [Abstract] [Full Text] [Related]
18. Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. Lin CY, Anders J, Johnson M, Sang QA, Dickson RB. J Biol Chem; 1999 Jun 25; 274(26):18231-6. PubMed ID: 10373424 [Abstract] [Full Text] [Related]
19. High-affinity cyclic peptide matriptase inhibitors. Quimbar P, Malik U, Sommerhoff CP, Kaas Q, Chan LY, Huang YH, Grundhuber M, Dunse K, Craik DJ, Anderson MA, Daly NL. J Biol Chem; 2013 May 10; 288(19):13885-96. PubMed ID: 23548907 [Abstract] [Full Text] [Related]